Autolus Therapeutics plc

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

Q: May 13 2024

FY: Dec 31 2023

Q: Sep 30 2023

FY: Dec 31 2022

FY: Dec 31 2021

FY: Dec 31 2020

FY: Dec 31 2019

FY: Dec 31 2019

FY: Dec 31 2018

FY: Sep 30 2018

Results of Operations and Financial Condition

Regulation FD Disclosure

Entry into a Material Definitive Agreement

Submission of Matters to a Vote of Security Holders

Other Events

Results of Operations and Financial Condition

Cost Associated with Exit or Disposal Activities

Changes in Registrant's Certifying Accountant

Regulation FD Disclosure

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Regulation FD Disclosure

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Submission of Matters to a Vote of Security Holders

Other Events

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Results of Operations and Financial Condition

Regulation FD Disclosure

Notice of Effectiveness

Prospectus Supplement for Primary Offering

No description available

Registration statement under Securities Act of 1933

Notice of Effectiveness

Notice of Effectiveness

No description available

No description available

Registration statement under Securities Act of 1933

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Prospectus Supplement for Primary Offering

Piccina Cintia

Piccina Cintia

PPF Group a.s.

ARMISTICE CAPITAL, LLC

Bain Linda

BONNEY MICHAEL W

YOUNG WILLIAM D

Rao Madduri Ravin

Richardson Ryan

Leiderman Elisabeth

Iannone Robert

BUTITTA CYNTHIA M

Azelby Robert

MAK Capital Fund LP

ARMISTICE CAPITAL, LLC

Richardson Ryan

BUTITTA CYNTHIA M

Berriman John E

BONNEY MICHAEL W

YOUNG WILLIAM D

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Post-effective amendment to an automatic shelf registration statement

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC